ATE262538T1 - Lhrh-analoga zur behandlung der osteoporose - Google Patents

Lhrh-analoga zur behandlung der osteoporose

Info

Publication number
ATE262538T1
ATE262538T1 AT99951005T AT99951005T ATE262538T1 AT E262538 T1 ATE262538 T1 AT E262538T1 AT 99951005 T AT99951005 T AT 99951005T AT 99951005 T AT99951005 T AT 99951005T AT E262538 T1 ATE262538 T1 AT E262538T1
Authority
AT
Austria
Prior art keywords
osteoporosis
treatment
lhrh analogues
image
lhrh
Prior art date
Application number
AT99951005T
Other languages
English (en)
Inventor
Karen Akinsanya
Amanda Hayward
Steve Qi
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of ATE262538T1 publication Critical patent/ATE262538T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Dental Preparations (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Luminescent Compositions (AREA)
AT99951005T 1998-10-27 1999-10-27 Lhrh-analoga zur behandlung der osteoporose ATE262538T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9823515A GB2343182A (en) 1998-10-27 1998-10-27 Use of GnRH-II and analogues thereof for the treatment of osteoporosis
PCT/GB1999/003553 WO2000024764A1 (en) 1998-10-27 1999-10-27 Lhrh analogues for the treatment of osteoporosis

Publications (1)

Publication Number Publication Date
ATE262538T1 true ATE262538T1 (de) 2004-04-15

Family

ID=10841385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951005T ATE262538T1 (de) 1998-10-27 1999-10-27 Lhrh-analoga zur behandlung der osteoporose

Country Status (7)

Country Link
EP (2) EP1124847B1 (de)
AT (1) ATE262538T1 (de)
AU (1) AU6358499A (de)
DE (1) DE69915852T2 (de)
DK (1) DK1124847T3 (de)
GB (1) GB2343182A (de)
WO (1) WO2000024764A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2523197C (en) 2003-04-22 2016-05-24 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide vectors
GB0616111D0 (en) 2006-06-16 2006-09-20 Ardana Bioscience Ltd Agents, methods and uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540513A (en) * 1984-09-25 1985-09-10 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Decapeptide having gonadotropin releasing activity
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4721775A (en) * 1985-08-26 1988-01-26 Board Of Regents, The University Of Texas System Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
EP1340768A2 (de) 2003-09-03
GB2343182A (en) 2000-05-03
DE69915852D1 (de) 2004-04-29
EP1124847B1 (de) 2004-03-24
WO2000024764A1 (en) 2000-05-04
EP1340768A3 (de) 2004-02-04
AU6358499A (en) 2000-05-15
DK1124847T3 (da) 2004-07-26
GB9823515D0 (en) 1998-12-23
EP1124847A1 (de) 2001-08-22
DE69915852T2 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
LU91281I2 (fr) Preotact-hormone parathyroïde
ATE394082T1 (de) Vorrichtung zur verbindung von wirbeln der wirbelsäule
BR9804437A (pt) Compostos para a osteoporose
DK1061940T3 (da) Anvendelse af follistatin til fremstilling af et medikament til behandling af muskelrelaterede lidelser
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
CL2003001743A1 (es) Compuestos derivados de leucinamida, inhibidores de la cisteina proteasa; composicion farmaceutica; procedimiento de preparacion de la composicion farmaceutica; y su uso en el tratamiento de la osteoporosis, enfermedad de paget's, peridontal, perdida
SE9901272D0 (sv) New improved formulation
DE50008238D1 (de) Aktiver marknagel zur distraktion von knochenteilen
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE284221T1 (de) Pflanzenextrakte zur behandlung einer gesteigerten knochenresorption
ATE262538T1 (de) Lhrh-analoga zur behandlung der osteoporose
ATE220915T1 (de) Einen basischen fibroblastwachstumsfaktor enthaltende mittel zur behandlung von knochenkrankheiten
DE69921346T8 (de) Pflanzenextrakte zur behandlung einer gesteigerten knochenresorption
ATE245637T1 (de) Benzothiophenverbindungen, zubereitungen und verfahren
AU5162196A (en) Novel peptides and remedy for bone diseases containing the same as active ingredient

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties